Ravi Barod

1.8k total citations
57 papers, 594 citations indexed

About

Ravi Barod is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Ravi Barod has authored 57 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 26 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Ravi Barod's work include Renal cell carcinoma treatment (39 papers), Renal and related cancers (22 papers) and Renal and Vascular Pathologies (10 papers). Ravi Barod is often cited by papers focused on Renal cell carcinoma treatment (39 papers), Renal and related cancers (22 papers) and Renal and Vascular Pathologies (10 papers). Ravi Barod collaborates with scholars based in United Kingdom, United States and Italy. Ravi Barod's co-authors include Patrick H. Maxwell, Miguel A. Esteban, Craig Rogers, Deepa Shukla, Axel Bex, Joana B. Neves, Faiz Mumtaz, Prasad Patki, Maxine Tran and Karl Matter and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and The Journal of Urology.

In The Last Decade

Ravi Barod

48 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Barod United Kingdom 14 365 324 175 161 59 57 594
Eduard Roussel Belgium 13 421 1.2× 237 0.7× 92 0.5× 183 1.1× 31 0.5× 65 606
Jason W. Anast United States 9 306 0.8× 154 0.5× 62 0.4× 113 0.7× 26 0.4× 12 495
Maria Furlan Italy 11 507 1.4× 282 0.9× 29 0.2× 197 1.2× 39 0.7× 30 558
Nirmal K. Veeramachaneni United States 14 546 1.5× 202 0.6× 119 0.7× 189 1.2× 26 0.4× 37 821
Clara Cerrato Italy 12 344 0.9× 167 0.5× 85 0.5× 121 0.8× 12 0.2× 70 523
Jamil Syed United States 14 475 1.3× 144 0.4× 66 0.4× 78 0.5× 17 0.3× 50 601
Jaime O. Herrera‐Cáceres Canada 10 182 0.5× 86 0.3× 62 0.4× 127 0.8× 26 0.4× 52 431
Norio Meguro Japan 10 251 0.7× 172 0.5× 60 0.3× 117 0.7× 13 0.2× 41 358
Hsiao‐Jen Chung Taiwan 13 419 1.1× 188 0.6× 45 0.3× 99 0.6× 11 0.2× 54 556
Jose Reyes United States 11 272 0.7× 206 0.6× 51 0.3× 95 0.6× 20 0.3× 24 428

Countries citing papers authored by Ravi Barod

Since Specialization
Citations

This map shows the geographic impact of Ravi Barod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Barod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Barod more than expected).

Fields of papers citing papers by Ravi Barod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Barod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Barod. The network helps show where Ravi Barod may publish in the future.

Co-authorship network of co-authors of Ravi Barod

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Barod. A scholar is included among the top collaborators of Ravi Barod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Barod. Ravi Barod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, Hannah, Naila Khalil, Giuseppe Basile, et al.. (2025). A Systematic Review and Meta-analysis of Oncological Outcomes of Treated and Untreated Complex Cystic Renal Masses. European Urology Focus.
2.
Neves, Joana B., Soha El Sheikh, Miles Walkden, et al.. (2023). Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor Prognoses. Urology. 176. 102–105. 1 indexed citations
3.
Campain, Nicholas, Yasmin Abu‐Ghanem, Marios Poullas, et al.. (2023). Not‐so‐simple nephrectomy: Comparative analysis of radical and simple nephrectomy in a high‐volume tertiary referral center. International Journal of Urology. 31(2). 160–168.
4.
Tan, Wei Shen, Nicholas Campain, Alexander P. Cole, et al.. (2022). Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. European Urology Focus. 9(2). 333–335. 1 indexed citations
5.
Beyer, Katharina, Lisa M. Wintner, Saeed Dabestani, et al.. (2022). A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer. European Urology Open Science. 48. 1–11. 4 indexed citations
6.
Hyde, Eoin, Faiz Mumtaz, Ravi Barod, et al.. (2022). Interactive virtual 3D image reconstruction to assist renal surgery in patients with fusion anomalies of the kidney. Journal of Clinical Urology. 16(4). 340–343. 3 indexed citations
7.
Tan, Wei Shen, Maya Marchese, Marco Paciotti, et al.. (2021). Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urology and Nephrology. 73(3). 404–406. 2 indexed citations
8.
Neves, Joana B., Yasmin Abu‐Ghanem, Marta Marchetti, et al.. (2021). Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. World Journal of Urology. 39(10). 3823–3831. 4 indexed citations
9.
Campi, Riccardo, Graziano Vignolini, Karel Decaestecker, et al.. (2020). Robot-assisted kidney transplantation (RAKT) from living donors using right- versus left-sided grafts: Results from the EAU Robotic Urology Section (ERUS)-RAKT working group. European Urology Open Science. 19. e1448–e1449. 1 indexed citations
10.
Neves, Joana B., John Withington, Sarah Fowler, et al.. (2018). Contemporary surgical management of renal oncocytoma: a nation's outcome. British Journal of Urology. 121(6). 893–899. 24 indexed citations
11.
Dalela, Deepansh, et al.. (2017). Initial robotic assistance in the surgical management of renal cell carcinoma with level 4 cavoatrial thrombus. Journal of Robotic Surgery. 12(4). 737–740. 6 indexed citations
12.
Withington, John, Joana B. Neves, & Ravi Barod. (2017). Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass. Current Urology Reports. 18(8). 61–61. 10 indexed citations
13.
Williamson, Sean R., Kiril Trpkov, Michelle S. Hirsch, et al.. (2017). Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Human Pathology. 63. 149–156. 78 indexed citations
14.
Chitale, Dhananjay, Ravi Barod, Craig Rogers, et al.. (2017). Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database. Modern Pathology. 30(11). 1603–1612. 26 indexed citations
15.
Barod, Ravi, Deepansh Dalela, Michael H. Johnson, et al.. (2016). Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes. Journal of Robotic Surgery. 11(1). 47–51.
16.
Sood, Anil K., Wooju Jeong, Ravi Barod, et al.. (2015). Robot‐assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: An IDEAL stage 0 study. Journal of Surgical Oncology. 112(7). 741–745. 7 indexed citations
17.
Sun, Lijun, Wen‐de Tian, Deepa Shukla, et al.. (2012). Epigenetic regulation of HIF-1 alpha in renal cancer cells involves HIF-1 alpha/2 alpha binding to a reverse hypoxia-response element. UCL Discovery (University College London). 2 indexed citations
18.
Bhattacharyya, Tapan, Petros Andrikopoulos, Miguel A. Esteban, et al.. (2011). Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis. British Journal of Cancer. 104(7). 1151–1159. 34 indexed citations
19.
Xu, Jianyong, Yan Xu, Li Sun, et al.. (2011). Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element. Oncogene. 31(8). 1065–1072. 30 indexed citations
20.
Tuthill, Mark, Ravi Barod, L Pyle, et al.. (2009). A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib. BMJ Case Reports. 2009. bcr0820080732–bcr0820080732. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Roussel Breakdown of academic impact, for papers by Jason W. Anast Breakdown of academic impact, for papers by Maria Furlan Breakdown of academic impact, for papers by Nirmal K. Veeramachaneni Breakdown of academic impact, for papers by Clara Cerrato Breakdown of academic impact, for papers by Jamil Syed Breakdown of academic impact, for papers by Jaime O. Herrera‐Cáceres Breakdown of academic impact, for papers by Norio Meguro Breakdown of academic impact, for papers by Hsiao‐Jen Chung Breakdown of academic impact, for papers by Jose Reyes
Rankless by CCL
2026